WA
PACB icon

WFG Advisors’s Pacific Biosciences PACB Stock Holding History

WFG Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$14K Buy
3,844
+1,144
+42% +$4.61K ﹤0.01% 1044
2017
Q1 		$14K Sell
2,700
-1,444
-35% -$7.07K ﹤0.01% 986
2016
Q4 		$16K Hold
4,144
– – ﹤0.01% 983
2016
Q3 		$37K Sell
4,144
-1,328
-24% -$11.1K 0.01% 778
2016
Q2 		$39K Sell
5,472
-1,186
-18% -$10.8K 0.01% 756
2016
Q1 		$57K Buy
6,658
+590
+10% +$5.8K 0.02% 630
2015
Q4 		$80K Sell
6,068
-16,430
-73% -$147K 0.02% 525
2015
Q3 		$82K Sell
22,498
-1,200
-5% -$5.87K 0.03% 501
2015
Q2 		$137K Buy
23,698
+21,790
+1,142% +$126K 0.04% 450
2015
Q1 		$11K Sell
1,908
-21,537
-92% -$149K ﹤0.01% 1176
2014
Q4 		$184K Buy
23,445
+850
+4% +$5.44K 0.04% 452
2014
Q3 		$111K Buy
22,595
+18,545
+458% +$97K 0.02% 628
2014
Q2 		$25K Sell
4,050
-1,000
-20% -$5K ﹤0.01% 1185
2014
Q1 		$27K Sell
5,050
-25,070
-83% -$158K 0.01% 1144
2013
Q4 		$158K Buy
30,120
+23,220
+337% +$107K 0.02% 588
2013
Q3 		$38K Sell
6,900
-800
-10% -$2.78K 0.01% 1028
2013
Q2 		$19K Buy
+7,700
New +$19.2K ﹤0.01% 1230

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

WFG Advisors's PACB Position: Q2 2017 in Review

WFG Advisors increased its Pacific Biosciences (PACB) stake by 42% in Q2 2017, buying an estimated $4.61K and bringing the position to 3,844 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

WFG Advisors first reported a position in PACB in Q2 2013 and has held it in 17 quarters since. The position peaked at $184K in Q4 2014. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2017.

  • WFG Advisors held 3,844 shares of Pacific Biosciences worth $14K as of Q2 2017.
  • WFG Advisors bought 1,144 Pacific Biosciences shares in Q2 2017, an estimated $4.61K.
  • Pacific Biosciences made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1044 holding.
  • WFG Advisors first reported a position in Pacific Biosciences in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's Pacific Biosciences position peaked at $184K in Q4 2014.
  • 107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.